ICSA-15-161-01

icsaUScisa_csaf_ot

Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities

Advisory ansehen veröffentlicht 2015-03-13

This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

01

beschreibt (7)

Zugehörige CVEs.

IDSchweregrad ausnutzbar
CVE-2015-3956UScritical9.8OT erhöht—
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, f…
CVE-2015-3954UScritical9.8—
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated use…
CVE-2015-3953UScritical9.8OT erhöht—
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, versi…
CVE-2015-3952UShigh7.5OT erhöht—
Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, versi…
CVE-2015-3958UShigh7.8—
Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP pa…
CVE-2015-3957USmedium4.6OT erhöht—
Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.
CVE-2015-3955UShigh10.0—
Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified…
02

Referenzen

Externe Belege — Patches, Meldungen, Analysen.

03

Behebungen (21)

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+ Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion System

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

scry

Advisories wie diese benennen die exponierten Produkte, die Angreifer auf Ihrer Angriffsfläche ins Visier nehmen. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.

Kostenloser Scan